Emerald Advisors, LLC Pfizer Inc Transaction History

Emerald Advisors, LLC

$695 Million
Q3 2024

A detailed history of Emerald Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Emerald Advisors, LLC holds 26,284 shares of PFE stock, worth $660,516. This represents 0.11% of its overall portfolio holdings.

Number of Shares

26,284

Previous 25,149 4.51%

Holding current value

$660,516

Previous $703,000 8.11%

% of portfolio

0.11%

Previous 0.11%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$27.7 - $31.39 $31,439 - $35,627	1,135 Added 4.51%	26,284 $760,000
Q2 2024 Jul 15, 2024	BUY	$25.26 - $29.6 $140,041 - $164,102	5,544 Added 28.28%	25,149 $703,000
Q1 2024 Apr 25, 2024	BUY	$25.89 - $29.73 $81,242 - $93,292	3,138 Added 19.06%	19,605 $544,000
Q4 2023 Jan 23, 2024	SELL	$26.13 - $33.94 $108,178 - $140,511	-4,140 Reduced 20.09%	16,467 $474,000
Q3 2023 Oct 13, 2023	BUY	$32.09 - $37.51 $157,080 - $183,611	4,895 Added 31.15%	20,607 $683,000
Q2 2023 Aug 02, 2023	BUY	$36.12 - $41.79 $52,121 - $60,302	1,443 Added 10.11%	15,712 $576,000
Q1 2023 Apr 07, 2023	BUY	$39.39 - $51.28 $20,167 - $26,255	512 Added 3.72%	14,269 $582,000
Q4 2022 Jan 20, 2023	SELL	$41.75 - $54.5 $27,763 - $36,242	-665 Reduced 4.61%	13,757 $0
Q3 2022 Oct 12, 2022	BUY	$43.76 - $53.42 $25,162 - $30,716	575 Added 4.15%	14,422 $631,000
Q2 2022 Aug 01, 2022	BUY	$46.53 - $55.17 $31,733 - $37,625	682 Added 5.18%	13,847 $726,000
Q1 2022 Apr 26, 2022	BUY	$45.75 - $56.69 $21,273 - $26,360	465 Added 3.66%	13,165 $682,000
Q4 2021 Jan 19, 2022	BUY	$41.32 - $61.25 $72,310 - $107,187	1,750 Added 15.98%	12,700 $750,000
Q3 2021 Nov 02, 2021	BUY	$39.25 - $50.42 $6,672 - $8,571	170 Added 1.58%	10,950 $471,000
Q2 2021 Aug 02, 2021	BUY	$35.91 - $40.68 $24,706 - $27,987	688 Added 6.82%	10,780 $422,000
Q1 2021 Apr 20, 2021	BUY	$33.49 - $37.77 $5,525 - $6,232	165 Added 1.66%	10,092 $366,000
Q4 2020 Feb 05, 2021	SELL	$33.47 - $42.56 $64,362 - $81,842	-1,923 Reduced 16.23%	9,927 $365,000
Q3 2020 Nov 10, 2020	BUY	$31.75 - $37.25 $10,826 - $12,702	341 Added 2.96%	11,850 $435,000
Q2 2020 Aug 10, 2020	SELL	$30.12 - $36.54 $9,939 - $12,058	-330 Reduced 2.79%	11,509 $376,000
Q1 2020 May 14, 2020	SELL	$27.03 - $38.62 $135,339 - $193,370	-5,007 Reduced 29.72%	11,839 $441,000
Q4 2019 Feb 12, 2020	BUY	$32.92 - $37.36 $554,570 - $629,366	16,846 New	16,846 $677,000

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Advisors, LLC with notifications on news.

Account

Emerald Advisors, LLC Pfizer Inc Transaction History